Detalhe da pesquisa
1.
Results of ARI-0001 CART19 cell therapy in patients with relapsed/refractory CD19-positive acute lymphoblastic leukemia with isolated extramedullary disease.
Am J Hematol
; 97(6): 731-739, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35253928
2.
CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed/Refractory Malignancies.
Mol Ther
; 29(2): 636-644, 2021 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33010231
3.
Outcomes for paediatric acute leukaemia patients admitted to the paediatric intensive care unit.
Eur J Pediatr
; 181(3): 1037-1045, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34694507
4.
Lower incidence of clinical allergy with PEG-asparaginase upfront versus the sequential use of native E. coli asparaginase followed by PEG-ASP in pediatric patients with acute lymphoblastic leukemia.
Hematol Oncol
; 39(5): 687-696, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34397119
5.
Paediatric patients with acute leukaemia and KMT2A (MLL) rearrangement show a distinctive expression pattern of histone deacetylases.
Br J Haematol
; 182(4): 542-553, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29978456
6.
Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring.
Front Immunol
; 15: 1373852, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38384474
7.
ECLIM-SEHOP: how to develop a platform to conduct academic trials for childhood cancer.
Clin Transl Oncol
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38600340
8.
Risk factors and outcome of Chimeric Antigen Receptor T-Cell patients admitted to Pediatric Intensive Care Unit: CART-PICU study.
Front Immunol
; 14: 1219289, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37600775
9.
Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring.
Front Immunol
; 14: 1280580, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38292483
10.
Spuriously low pulse oximetry saturation associated with hemoglobin Sydney in a child and relatives: Identification of this unstable hemoglobin may avoid unnecessary testing and hospital admissions.
Pediatr Blood Cancer
; 64(5)2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27808457
11.
Aplastic Crisis Secondary to Parvovirus B19 Infection as the First Manifestation of an Undiagnosed Hereditary Spherocytosis: Report of a Pediatric Series of Spanish Patients.
J Pediatr Hematol Oncol
; 38(1): 81-2, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26583618
12.
Factors associated with the clinical outcome of patients with relapsed/refractory CD19+ acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy.
J Immunother Cancer
; 9(12)2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34907029